E. Quoix (Strasbourg, France), K. Syrigos (Athens, Greece)
A cost minimisation comparison of five chemotherapy regimes for advanced nonsmall cell lung cancer
H. G. Bischoff, D. Tilden, A. Kielhorn, C. Heuser (Heidelberg, Bad Homburg, Germany; London, United Kingdom)
|  |
Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
B. Çaglayan, A. Fidan, B. Salepçi, N. Kiral, T. Salepçi, A. Mayadagli (Istanbul, Turkey)
| |
Measurement of individual quality of life in patients with lung cancer receiving palliative chemotherapy
E. Mannion, D. Waldron, T. Azher, J. J. Gilmartin (Galway, Ireland)
| |
Audit of process of care of elderly patients with lung cancer
B. A. Hamilton, N. Magee, R. Convery (Craigavon, United Kingdom)
| |
Some characteristics of patients with lung cancer elected for palliative treatment
G. D. Radosavljevic-Asic, D. Pesut, A. Blanka, V. Kacar (Belgrade, Yugoslavia)
| |
The need for early MDT assessment of lung cancer patients presenting with pain
M. Al-Aloul, M. Ellison, J. Hughes, M. J. Ledson, M. J. Walshaw (Liverpool, United Kingdom)
| |
Morphine prescription to terminally-ill patients suffering from lung cancer
H. Pegliasco, M. K. Ben Diane, P. Peretti, Y. Obadia (Marseilles, France)
| |
Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization
A. Miroslaw, M. Koziol-Montewka, A. Chudnicka, A. Milczak, S. Jablonka (Rabka, Qatar; Lublin, Poland)
| |
Effect of cisplatin on bacterial translocation in an experimental model whit increased intestinal microflora
B. Ulubas, G. Ersoz, B. Coskun, M. Tumkaya, H. Camdeviren (Mersin, Turkey)
| |
Ibandronate: efficient in managing lung cancer associated hypercalcaemia
A. G. Charpidou, I. Danos, G. Dionellis, N. Philippou, N. Georgatou, H. Lambrakis, K. N. Syrigos (Athens, Greece)
| |
Successful and quick desensitization to docetaxel
A. G. Charpidou, E. Psaras, E. Syrigou, I. Danos, E. Gondrogia, H. Karapanagiotou, K. N. Syrigos (Athens, Greece)
| |
Superior vena cava obstruction and non-small cell lung cancer: stent as gold-standard?
L. Greillier, F. Barlesi, C. Doddoli, J. P. Torre, O. Durieux, C. Gimenez, J. P. Kleisbauer (Marseille, France)
| |
Diffuse alveolar damage/ARDS induced by docetaxel proved by open lung biopsy
C. C. Huang, H. C. Hu, Y. H. Tsai (Taoyuan, Taiwan)
| |
Large mediastinal mass with unusual appearance
O. Ailoaie, A. Macri, I. Cordos, M. Orchidan, R. T. Stoica, P. Galbenu (Bucharest, Romania)
| |
Study of the secondary lung involvement by lymphomas using the WHO classification
M. B. G. Costa, S. A. C. Siqueira, P. H. N. Saldiva, T. Mauad (Sao Paulo, Brazil)
| |
Solitary pleural fibroma. A 3 cases report
S. Bousnina, K. Marniche, E. Hassine, H. Lengliz, M. L. Megdiche, A. Chabbou (Ariana, Tunisia)
| |
Myeloid leukomoid reaction in a case with pleomorphic type lung carcinoma
R. Dodurgali, S. Sariyildiz, M. Yilmaz, S. Guven, N. Urer, M. Bedirhan, A. Poluman (Istanbul, Turkey)
| |